BioMonde's Series A Round

BioMonde raised a round of funding on June 02, 2014.

BioMonde is a European wound care company specialising in the manufacture and distribution of larval debridement therapy (also known as maggot therapy) products for use in chronic and hard to heal wou…

Articles about BioMonde's Series A Round: